VALARTH See the full analysis in the appOpen in app
Sectoral / Thematic · Equity

HDFC Pharma and Healthcare Fund

HDFC Asset Management Company Limited
Benchmark
BSE Healthcare TRI
Riskometer
Very High
Size
₹3,505 cr
Allotted
4 Oct 2023
Holdings as of
30 Sep 2026

HDFC Pharma and Healthcare Fund is a sectoral / thematic fund of HDFC Asset Management Company Limited with ₹3,505 cr under management. It is ahead of its benchmark (BSE Healthcare TRI) in 2 of 2 periods. Its direct plan charges 1.05% a year. Nikhil Mathur has managed it for 3.0 years.

Has HDFC Pharma and Healthcare Fund beaten its benchmark?

Ahead of its benchmark, BSE Healthcare TRI, in 2 of 2 periods in AMFI's figures; +21.60% over the last year against +9.74%.

Period returns

Direct Plan, growth · 3y and longer a year
PeriodFundNifty 500 TRIAhead
1 month−5.35% −3.60% —
3 months+0.04% −5.03% —
6 months+19.76% −1.83% —
1 year+21.60% −4.06% +25.66 pts
3 years+28.89% +9.27% +19.62 pts
5 years— +8.00% —
10 years— +12.69% —
Since start
from 4 Oct 2023
+28.94%——
Valarth price history to 13 Oct 2026 · the index is the one the fund is nearest; — not on record

Official figures

AMFI performance feed, 13 Oct 2026
Ahead of its benchmark (BSE Healthcare TRI) in 2 of 2 periods.
PeriodDirectRegularBenchmarkAheadRank
1y +21.60%+20.24%+9.74% +11.86 🔒
3y +28.84%+27.33%+20.52% +8.32 🔒
5y ——— — —
10y ——— — —
Ahead in points a year · its rank among Sectoral / Thematic funds, and how steady the lead is, in the app

Value of 100, month-end

Oct 2023 to 13 Oct 2026
100150200250 2025
Fund 218Nifty 500 TRI 135

₹100 put in at the start of Oct 2023 would be ₹218 on 13 Oct 2026, against ₹135 in the Nifty 500 TRI.

Risk, falls and every year

🔒 Pro
Its worst fall and how long it took to recover, three-year stretches, Sharpe, beta and capture ratios, calendar years beside the index, and money in and out: in the app.
See them in the app →

What does HDFC Pharma and Healthcare Fund cost?

1.05% a year on the direct plan, 2.13% on the regular plan; 53 of 174 funds in its category charge less.

Direct plan
1.05% a year
Category median 1.22%
Regular plan
2.13% a year
Category median 2.38%
Gap
1.08 points
for the same holdings
53 of 174 funds in its category charge less on the direct plan.
Expense report, Oct 2026 · Equity Scheme - Sectoral/ Thematic

What the regular plan costs you over time

🔒 Pro
The same money left for years in the direct and the regular plan, side by side, and what the commission takes: in the app.

Who manages HDFC Pharma and Healthcare Fund?

Nikhil Mathur, since 4 Oct 2023; Gopal Agrawal, since 1 Sep 2026; Bhagyesh Kagalkar, since 26 Aug 2026.

Nikhil Mathur
3.0 years
since 4 Oct 2023
Gopal Agrawal
0.1 years
since 1 Sep 2026
Bhagyesh Kagalkar
0.1 years
since 26 Aug 2026
Benchmark as filedBSE Healthcare Index (TRI)
Exit load
In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched out after 30 days from the date of allotment.
From 7 Scheme Summary Documents filed with NSE, first on 12 Apr 2026; as on 13 Oct 2026

What does HDFC Pharma and Healthcare Fund hold?

40 holdings as of 30 Sep 2026; the ten largest are 47.8% of the fund, the largest Divis Laboratories Ltd. at 9.4%.

Mix

Holdings as of 30 Sep 2026
Equity96.8%Debt0.0%Cash3.2%Other0.0%
Holdings
40
38 shares
Top ten
47.8%
of the fund
Effective holdings
24.7
spread, as if equal-weighted
Matched to our table
100%
of the equity

Five largest

% of fund
Divis Laboratories Ltd.9.39%
Sun Pharmaceutical Industries Ltd.8.28%
Alkem Laboratories Ltd.4.64%
Cipla Ltd.4.15%
Apollo Hospitals Enterprise Ltd.3.69%

Five largest industries

% of fund
Pharmaceuticals & Biotechnology73.6%
Healthcare Services22.9%
Healthcare Equipment & Supplies2.40%
Retailing1.00%

By company size

% of equity · SEBI size lists
Large Cap30.1%Mid Cap31.1%Small Cap38.8%

How does HDFC Pharma and Healthcare Fund score against its category?

Seven scores against funds of its kind, and the warning signs it trips.

Scorecard

🔒 Pro
Seven scores, each out of 5, against funds in its category, with the reasons, and the warning signs it trips: in the app.
Open scorecard in the app →

Are the companies inside any good?

The holdings by valuation, forensic risk, business quality and balance sheet, weighted by their share of the fund.

The companies inside

🔒 Pro
The holdings weighted by their share of the fund: P/E and ROE, forensic risk levels, Valarth's valuation view, quality, moats, balance sheets and who owns them: in the app.

How is HDFC Pharma and Healthcare Fund run?

Turnover, what it bought and sold, its cash and its record in new listings, from its monthly holdings files.

How it is run

🔒 Pro
Turnover, what it bought and sold and when, how long it holds, size drift, cash and its record in new listings, from up to two years of monthly holdings files: in the app.

Which funds hold much the same?

The index it is nearest and the funds whose holdings overlap most.

not an index tracker
Nearest to the Nifty Next 50: 91% of it differs from the index (an active fund is usually above 60%).
Active share 91.1%60%

Funds that hold much the same

% of holdings in common
Mirae Asset Nifty 500 Healthcare ETF62.7% the same
25 shared holdings
Motilal OswalBSE Healthcare ETF61.1% the same
35 shared holdings
Bandhan BSE Healthcare Index Fund61.1% the same
35 shared holdings

How much is in its sponsor's own group?

Holdings in companies of the fund house's sponsor group, beside the index.

Related-party exposure

🔒 Pro
How much of the fund is in companies of its sponsor's own group, beside what the index holds of them: in the app.

Questions people ask

Who manages HDFC Pharma and Healthcare Fund?

Nikhil Mathur (manager) since 4 Oct 2023; Gopal Agrawal (manager) since 1 Sep 2026; Bhagyesh Kagalkar (manager) since 26 Aug 2026.

What is the expense ratio of HDFC Pharma and Healthcare Fund?

1.05% a year on the direct plan and 2.13% on the regular plan (expense report, Oct 2026).

How has HDFC Pharma and Healthcare Fund done?

Its direct plan returned +28.84% a year over 3 years against +20.52% for its benchmark, BSE Healthcare TRI, as of 13 Oct 2026.

Inside the app

See HDFC Pharma and Healthcare Fund beside your own funds in Valarth

Start freeStart free
A Valarth stock page: the share price with its chart and 52-week range, valuation and profitability figures, and a scorecard of health checks.
Stock pagePrice, valuation, profitability and a scorecard of health checks for every company, each figure explained.
The Valarth stock screener: a table of companies with price, market cap, P/E, P/B, PEG, EPS and ROE, and filters down the left.
ScreenerEvery listed company, filtered on 212 figures, each with a plain-language lesson beside it.
The Valarth AI Screener answering 'Which companies will benefit from India's Project 75 submarine programme?' with a basket of four naval shipbuilders and a written thesis.
AI ScreenerAsk a question in plain English, like which companies benefit from India's Project 75. It reads the intent, builds the screen and writes the thesis.
A Valarth business-model card for State Bank of India, with a plain-language summary and statements verified against the filing.
Business modelHow a company makes money and what can hurt it, each statement checked against its annual report.
Valarth's Before the Bell edition, with the day's headline, regulator notes and sector moves.
Before the BellA morning edition before the market opens: what moved, which rule changed, and what it means for your holdings.

HDFC Pharma and Healthcare Fund in the app: beside your own funds, with what you own through them

See the full analysis in the app →See pricing
Share this page